PLATFORM PROFILEROG.SW
Roche
3.88
B-index (V3.1)
BLACK HOLE
Capture1.432
Escape0.369
Key Structural Insight
Diagnostics-pharma integration creates lock-in invisible to drug-only analysis. Companion diagnostics trap hospitals in the ecosystem.
Eleven-Parameter Profile
Data Depth8/10
Memory7/10
Action7/10
Process8/10
Network7/10
Closeness7/10
Portability3/10
Substitutability4/10
Human Fallback4/10
Org Depth8/10
Momentum6/10
Capture Escape Extended
V3.1 Decomposition
| Component | Value | Formula |
|---|---|---|
| CES₄ capture core | 0.7492 | CES(d, m, a, p) |
| Knowledge synergy σₖ | 0.7483 | √(d · m) |
| Operability synergy σₒ | 0.7483 | √(a · p) |
| Synergy boost | 1.2245 | 1 + 0.3·(σₖ + σₒ)/2 |
| Org-depth multiplier | 1.4000 | 1 + 0.5·o |
| Momentum multiplier | 1.1800 | 1 + 0.3·t |
| Total Capture | 1.4321 | c·(1+0.5n)·core·syn·org·mom |
| CES₃ escape core | 0.3651 | CES(x, s, h) |
| Feedback attenuation | 0.7378 | max(0.3, 1 − 0.35·core) |
| Total Escape | 0.3693 | ε + escCore · feedback |
| B = Capture / Escape | 3.88 | 1.432 / 0.369 |
Scoring Rationale
Diagnostics + Pharma integrated. Hospitals using Roche diagnostic platforms build entire workflows around specific reagents and protocols. Drug-diagnostic companion tests create bilateral lock-in. Decades of clinical data in Roche formats.
Parameter Sensitivity
MARGINAL B-INDEX CHANGE PER ±1 SCORE SHIFT
CLOSE7+1.11
PORT3-0.58
SUB4-0.50
FALL4-0.50
MEM7+0.39
ACT7+0.39
DATA8+0.36
PROC8+0.36
NET7+0.29
ORG8+0.28
MOM6+0.20
+ raises B (deepens lock-in)− lowers B (aids escape)